Buy ATAI by Sep 15, 2026.

Here’s a more natural, conversational version: I’ve been thinking about how pharma companies will always try to commercialize human problems and maximize profits for as long as they can. With that in mind, I feel like companies developing new therapies and molecules for conditions such as depression, ADHD, and addiction could be one of the next major growth areas in pharma. I’m thinking of companies like Definium Therapeutics, Atai Life Sciences, and Compass Pathways. As mental health treatments continue to …